Pitt-Hopkins Syndrome — Research Summary
Printed from RareWays (rareways.com.au) on 5 April 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
A photothermal antibacterial hydrogel based on a "nano-bridge" strategy with high toughness and self-healing capacity.
Wang Junyan et al. — Journal of colloid and interface science (15 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41638078/
- 2.
Effects of long-term exposure to ocean acidification on the Patagonian scallop Zygochlamys patagonica (P.P. king, 1832), a strategic fishery resource in the Southwest Atlantic ocean.
Lomovasky B J et al. — Marine environmental research (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41795391/
- 3.
Rapid high-throughput antibody analysis using microwave-assisted digestion.
de Toledo Thais Mingatos et al. — Journal of proteomics (20 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41570892/
- 4.
Demonstration of a
Kmak Kelly N et al. — Journal of chromatography. A (12 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41740335/
- 5.
Primary hyperoxaluria(s): from trials to real-life data and pipeline therapies.
Bacchetta Justine et al. — Kidney international (1 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41579959/
Clinical Trials — Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Recruiting — Phase 3 — AstraZeneca
https://clinicaltrials.gov/study/NCT05774951
- 2.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Recruiting — Phase 3 — AstraZeneca
https://clinicaltrials.gov/study/NCT06283966
- 3.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Recruiting — Phase 3 — Boehringer Ingelheim
https://clinicaltrials.gov/study/NCT07064473
- 4.
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Recruiting — Phase 3 — Novo Nordisk A/S
https://clinicaltrials.gov/study/NCT05636176
- 5.
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Recruiting — Sanford Health
https://clinicaltrials.gov/study/NCT01793168
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Pitt-Hopkins Syndrome
Pitt-Hopkins syndrome is a rare neurodevelopmental condition caused by mutations in the TCF4 gene, causing intellectual disability, absent speech, characteristic facial features, and distinctive breathing abnormalities. Diagnosis has increased with molecular genetic testing. Research into TCF4 restoration strategies is emerging.
Most Recent Research
Constructing integrated multifunctional hydrogels with both high toughness and diverse functionalities is beneficial for the development of flexible antibacterial materials and wearable sensors. However, current hydrogels often fail to achieve a synergistic balance among toughness, antibacterial activity, and sensing responsiveness, limiting their practical applications. Herein, a "nano-bridge" strategy is proposed to fabricate a double-network hydrogel system (PHS-CT) composed of a covalent polyacrylamide network and a dynamic borate-crosslinked hydroxypropyl guar gum/sodium alginate network. The incorporated Cu-TA nanosheets serve not only as "structural bridges" to enhance the crosslinking density and mechanical performance (strain up to 1997.7%, toughness up to 1.53 MJ/m3), but also as "functional bridges" to enable photothermal conversion and improved antibacterial activity (bacterial killing rate of 99.0% against E. coli under NIR irradiation). In addition, benefiting from the dynamic reversibility of borate ester bonds as well as the re-forming capability of hydrogen bonds at the fracture interface, the hydrogel exhibits favorable self-healing ability (self-healing efficiency up to 91.0%), and can function as a flexible strain sensor capable of accurately detecting both large-scale and subtle deformations. This strategy provides a feasible strategy for constructing multifunctional dual-network hydrogels, and may be useful for photothermal antibacterial and flexible sensing applications.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.